| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | A S Wolberg | |
| B L Walton | |||
| J R Byrnes | |||
| P2860 | cites work | Sickle cell trait and the risk of venous thromboembolism among blacks | Q28296523 |
| Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model | Q30439336 | ||
| Fibrin fibers have extraordinary extensibility and elasticity | Q30479919 | ||
| The mechanical properties of single fibrin fibers. | Q30497764 | ||
| Strength and failure of fibrin fiber branchpoints | Q30497788 | ||
| Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. | Q30539510 | ||
| Red cell-derived microparticles (RMP) as haemostatic agent | Q33410290 | ||
| Hematocrit and risk of venous thromboembolism in a general population. The Tromso study | Q33632252 | ||
| Global transcriptome analyses of human and murine terminal erythroid differentiation | Q33697238 | ||
| The elasticity of an individual fibrin fiber in a clot | Q33879142 | ||
| The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice | Q33902971 | ||
| Factor XIII activity mediates red blood cell retention in venous thrombi | Q33944224 | ||
| Lytic resistance of fibrin containing red blood cells. | Q33954228 | ||
| α-α Cross-links increase fibrin fiber elasticity and stiffness | Q34120791 | ||
| Structural origins of fibrin clot rheology | Q34171813 | ||
| Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology. | Q34171820 | ||
| Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study | Q34305696 | ||
| Thrombin generation and fibrin clot structure | Q34598931 | ||
| Molecular mechanisms affecting fibrin structure and stability | Q34759786 | ||
| Elastic behavior and platelet retraction in low- and high-density fibrin gels | Q34862881 | ||
| Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice | Q35001664 | ||
| Functional factor XIII-A is exposed on the stimulated platelet surface | Q35023065 | ||
| Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. | Q35346495 | ||
| Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation | Q36370881 | ||
| Submillisecond elastic recoil reveals molecular origins of fibrin fiber mechanics | Q36939701 | ||
| Platelet retraction force measurements using flexible post force sensors | Q37032473 | ||
| Venous thromboembolic events and erythropoiesis-stimulating agents: an update | Q37155173 | ||
| The pleiotropic role of the fibrinogen gamma' chain in hemostasis | Q37581345 | ||
| Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. | Q37623550 | ||
| Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism | Q37629233 | ||
| Factor XIII and venous thromboembolism | Q37860238 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Intercellular adhesion molecule-4 binds alpha(4)beta(1) and alpha(V)-family integrins through novel integrin-binding mechanisms | Q40795271 | ||
| Involvement of fibrinogen specific binding in erythrocyte aggregation | Q41858099 | ||
| Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6. | Q42218786 | ||
| The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking. | Q42326716 | ||
| Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes | Q42929227 | ||
| Thrombophilia in sickle cell disease: the red cell connection | Q43806490 | ||
| Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. | Q44001534 | ||
| Integrin-associated protein (CD47) is a putative mediator for soluble fibrinogen interaction with human red blood cells membrane | Q44159019 | ||
| Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin | Q44246029 | ||
| Characterization of ICAM-4 binding to the I domains of the CD11a/CD18 and CD11b/CD18 leukocyte integrins | Q44402639 | ||
| Interaction of factor XIII subunits | Q44792819 | ||
| Cardiovascular events and intensity of treatment in polycythemia vera | Q44793541 | ||
| Plasma viscosity levels in pulmonary thromboembolism. | Q45144877 | ||
| Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma | Q45385966 | ||
| Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement | Q45897609 | ||
| The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. | Q45906428 | ||
| Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway | Q46970925 | ||
| Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke. | Q48723305 | ||
| Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. | Q50590954 | ||
| The effect of red blood cells on thrombin generation. | Q50736139 | ||
| The hemostatic effect of packed red cell transfusion in patients with anemia. | Q50854748 | ||
| Fibrinogen gene regulation. | Q51573124 | ||
| Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function. | Q52840471 | ||
| Interactions between factor XIII and the alphaC region of fibrinogen. | Q52846367 | ||
| Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. | Q52860275 | ||
| The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. | Q52863894 | ||
| Contribution of erythrocytes to thrombin generation in whole blood. | Q53891649 | ||
| Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. | Q54186562 | ||
| Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis. | Q54191211 | ||
| Binding Sites of Leukocyte β2Integrins (LFA-1, Mac-1) on the Human ICAM-4/LW Blood Group Protein | Q58199197 | ||
| Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans | Q64130189 | ||
| Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition | Q67316135 | ||
| Interactions of factor XIII with fibrin as substrate and cofactor | Q67731909 | ||
| Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII | Q69894095 | ||
| Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule | Q70039500 | ||
| Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA | Q70410242 | ||
| Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation | Q70791684 | ||
| The binding of fibrinogen and fibrinogen degradation products to the erythrocyte membrane and its relationship to haemorheology | Q71021514 | ||
| Erythrocyte aggregation and erythrocyte deformability modify the permeability of erythrocyte enriched fibrin network | Q71325596 | ||
| Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS) | Q72841203 | ||
| Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia | Q72992339 | ||
| Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A | Q73139419 | ||
| A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation | Q73686681 | ||
| Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions | Q77871735 | ||
| Cause-effect relation between hyperfibrinogenemia and vascular disease | Q79291740 | ||
| High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly | Q79366295 | ||
| Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence | Q79786324 | ||
| Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness | Q80160260 | ||
| Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels | Q81168187 | ||
| Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa | Q84002651 | ||
| Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies | Q84041978 | ||
| Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives | Q84426916 | ||
| Venous thrombosis | Q89217812 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | S208-15 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Fibrinogen, red blood cells, and factor XIII in venous thrombosis | |
| P478 | volume | 13 Suppl 1 |
| Q58751094 | Chronic kidney disease can increase the risk of preoperative deep vein thrombosis in middle-aged and elderly patients with hip fractures |
| Q58554769 | Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) cross-linking via tissue transglutaminase |
| Q89870468 | Effect of intravitreal injection of aflibercept on blood coagulation parameters in patients with age-related macular degeneration |
| Q51355462 | Impact of postoperative drainage autologous blood re-transfusion on the coagulation parameters and D-dimer levels of patients after total hip arthroplasty. |
| Q90541856 | Perioperative Transfusions and Venous Thromboembolism |
| Q39749262 | Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis |
| Q26739684 | Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting |
| Q93092111 | Reduced Contraction of Blood Clots in Venous Thromboembolism Is a Potential Thrombogenic and Embologenic Mechanism |
| Q37681886 | Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association? |
| Q94530351 | Shining a Light on Venous Thromboembolism |
| Q59355993 | The coagulation system in host defense |
| Q36546334 | Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS) |
Search more.